CURA — Curaleaf Holdings Share Price
0.000.00%
Last trade - 00:00- CA$1.01bn
- CA$2.35bn
- $1.34bn
- 75
- 81
- 16
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.85 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 11.36 | ||
| Price to Sales | 0.55 | ||
| EV to EBITDA | 7.84 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.32% | ||
| Return on Equity | -21.93% | ||
| Operating Margin | -2.52% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 626.64 | 1,195.99 | 1,275.42 | 1,346.63 | 1,342.8 | 1,344.58 | 1,437.78 | 43.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Curaleaf Holdings, Inc. is an international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof, provide service, product selection and accessibility across the medical and adult use markets. It has operations in about 17 states and operates 151 dispensaries, 19 cultivation sites and 20 manufacturing facilities, through which it sells cannabis through wholesale channels. The Company places a premium on populated, limited license states, including Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New York, New Jersey, North Dakota, Ohio and Pennsylvania. It cultivates, processes, markets and/or dispenses a wide range of permitted cannabis products across its operating markets, including flowers, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, mints and lozenges, topical balms and lotions, tinctures, and others.
Directors
- Boris Jordan CHM (54)
- Matt Darin PRE
- Joseph Bayern CEO (57)
- Joseph Lusardi VCH (47)
- Ranjan Kalia CFO (60)
- Carlos Madrazo SVP
- Talley Wettlaufer SVP
- Jim Shorris CCO (60)
- Peter Clateman OTH (53)
- Mitchell Kahn DRC (60)
- Peter Derby IND (60)
- Jaswinder Grover IND (55)
- Karl Johansson IND (71)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 13th, 2014
- Public Since
- October 22nd, 2015
- No. of Employees
- 5,519
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 756,531,066
- Address
- 420 Lexington Avenue, NEW YORK, 10170
- Web
- https://ir.curaleaf.com/
- Phone
- +1 7814510117
- Auditors
- PKF O'Connor Davies
Upcoming Events for CURA
Q1 2025 Curaleaf Holdings Inc Earnings Call
Curaleaf Holdings Inc Annual Shareholders Meeting
Q2 2025 Curaleaf Holdings Inc Earnings Release
Similar to CURA
Aptose Biosciences
Toronto Stock Exchange
Aurora Cannabis
Toronto Stock Exchange
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
FAQ
What is the Curaleaf Holdings share price?
As of Today at 20:08 UTC, shares in Curaleaf Holdings are trading at CA$1.34. This share price information is delayed by 15 minutes.
How has the Curaleaf Holdings share price performed this year?
Shares in Curaleaf Holdings last closed at CA$1.34 and the price had moved by -81.28% over the past 365 days. In terms of relative price strength the Curaleaf Holdings share price has underperformed the Toronto Stock Exchange 300 Composite Index by -83.13% over the past year.
What are the analyst and broker recommendations for Curaleaf Holdings?
The overall consensus recommendation for Curaleaf Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Curaleaf Holdings dividend yield?
Curaleaf Holdings does not currently pay a dividend.
Does Curaleaf Holdings pay a dividend?
Curaleaf Holdings does not currently pay a dividend.
When does Curaleaf Holdings next pay dividends?
Curaleaf Holdings does not currently pay a dividend.
How do I buy Curaleaf Holdings shares?
To buy shares in Curaleaf Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Curaleaf Holdings?
As of the previous close price of CA$1.34, shares in Curaleaf Holdings had a market capitalisation of CA$1.01bn.
Where are Curaleaf Holdings shares listed?
Here are the trading details for Curaleaf Holdings:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: CURA
What kind of share is Curaleaf Holdings?
Based on an overall assessment of its quality, value and momentum Curaleaf Holdings is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Curaleaf Holdings share price forecast for 2025?
The analyst consensus target price for shares in Curaleaf Holdings is CA$4.16. That is 210.7% above the last closing price of CA$1.34.
Analysts covering Curaleaf Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$0.22 for the next financial year.
Find out moreWhat is the trend in the Curaleaf Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Curaleaf Holdings. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -68.37%.
As of the last closing price of CA$1.34, shares in Curaleaf Holdings were trading -56.92% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Curaleaf Holdings PE Ratio?
The Curaleaf Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$1.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Curaleaf Holdings?
Curaleaf Holdings' management team is headed by:
- Boris Jordan - CHM
- Matt Darin - PRE
- Joseph Bayern - CEO
- Joseph Lusardi - VCH
- Ranjan Kalia - CFO
- Carlos Madrazo - SVP
- Talley Wettlaufer - SVP
- Jim Shorris - CCO
- Peter Clateman - OTH
- Mitchell Kahn - DRC
- Peter Derby - IND
- Jaswinder Grover - IND
- Karl Johansson - IND